<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Gastroenterol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Gastroenterol</journal-id>
<journal-title-group>
<journal-title>Journal of Gastroenterology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0944-1174</issn>
<issn pub-type="epub">1435-5922</issn>
<publisher>
<publisher-name>Springer Japan</publisher-name>
<publisher-loc>Tokyo</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29075899</article-id>
<article-id pub-id-type="pmc">5971039</article-id>
<article-id pub-id-type="publisher-id">1400</article-id>
<article-id pub-id-type="doi">10.1007/s00535-017-1400-8</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Immunoglobulin A and liver diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5160-2325</contrib-id>
<name>
<surname>Inamine</surname>
<given-names>Tatsuo</given-names>
</name>
<address>
<phone>+81-95-819-8575</phone>
<email>inaminet@nagasaki-u.ac.jp</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Schnabl</surname>
<given-names>Bernd</given-names>
</name>
<address>
<phone>858-822-5311</phone>
<email>beschnabl@ucsd.edu</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8902 2273</institution-id><institution-id institution-id-type="GRID">grid.174567.6</institution-id><institution>Department of Pharmacotherapeutics, </institution><institution>Nagasaki University Graduate School of Biomedical Sciences, </institution></institution-wrap>1-7-1 Sakamoto, Nagasaki, 852-8102 Japan </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution>Department of Medicine, </institution><institution>University of California, San Diego, </institution></institution-wrap>MC0063, 9500 Gilman Drive, La Jolla, San Diego, CA 92093 USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0419 2708</institution-id><institution-id institution-id-type="GRID">grid.410371.0</institution-id><institution>Department of Medicine, </institution><institution>VA San Diego Healthcare System, </institution></institution-wrap>San Diego, CA 92161 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>53</volume>
<issue>6</issue>
<fpage>691</fpage>
<lpage>700</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium from pathogenic microorganisms, and to help for immune-system development. The liver is the front-line organ that receives gut-derived products through the portal vein, implying that the liver could be severely affected by a disrupted intestinal homeostasis. Indeed, some liver diseases like alcoholic liver disease are associated with an altered composition of gut microbiota and increased blood endotoxin levels. Therefore, deficiency of SIgA function appears as a significant factor for the pathogenesis of liver diseases associated with altered gut microbiome. In this review, we describe SIgA functions on the gut microbiome and discuss the role of IgA for liver diseases, especially alcoholic liver disease and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>IgA</kwd>
<kwd>ALD</kwd>
<kwd>NAFLD</kwd>
<kwd>NASH</kwd>
<kwd>Gut microbiome</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id>
<institution>Japan Society for the Promotion of Science</institution>
</institution-wrap>
</funding-source>
<award-id>17K15953</award-id>
<principal-award-recipient>
<name>
<surname>Inamine</surname>
<given-names>Tatsuo</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000027</institution-id>
<institution>National Institute on Alcohol Abuse and Alcoholism</institution>
</institution-wrap>
</funding-source>
<award-id>R01 AA020703</award-id>
<award-id>U01 AA24726</award-id>
<award-id>U01 AA021856</award-id>
<principal-award-recipient>
<name>
<surname>Schnabl</surname>
<given-names>Bernd</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007496</institution-id>
<institution>Biomedical Laboratory Research and Development, VA Office of Research and Development</institution>
</institution-wrap>
</funding-source>
<award-id>I01BX002213</award-id>
<principal-award-recipient>
<name>
<surname>Schnabl</surname>
<given-names>Bernd</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Japanese Society of Gastroenterology 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par2">The human gut microbiota, comprised of 100 trillion bacteria with a high diversity, has established a mutualistic relationship with their host. While hosts provide a nutrient-rich environment, bacteria metabolize indigested foods, produce beneficial products like vitamins, and educate our immune system. Although the gut microbiota homeostasis is tightly regulated by both host and microbiota themselves, deviation from this highly balanced condition influences our health. A disrupted intestinal homeostasis is not only associated with gut disorders like inflammatory bowel diseases [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] but also with extraintestinal manifestations such as obesity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>], diabetes [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], autism spectrum disorder [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], and liver diseases [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par3">To maintain the homeostasis, the gut mucosa releases anti-microbial peptides and secretory immunoglobulins [<xref ref-type="bibr" rid="CR12">12</xref>]. Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and several grams of IgA are secreted into the intestine each day in humans [<xref ref-type="bibr" rid="CR13">13</xref>]. Plasma cells in the intestinal lamina propria secrete IgA, which is transcytosed across intestinal epithelial cells by a cellular receptor, polymeric-immunoglobulin receptor (pIgR) [<xref ref-type="bibr" rid="CR14">14</xref>]. In the gut lumen, secretory IgA controls microbiota composition and also serves as the first-line barrier that binds bacteria, limits contact between bacteria and enterocytes to prevent bacterial invasion [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Mice that lack functional IgA in the gut showed altered microbial composition and increased susceptibility to infectious diseases [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. In addition, mice carrying a genetic mutation in activation-induced cytidine deaminase, which cannot undergo somatic hyper mutation and class switching to IgA and IgG, have bacterial translocation and intestinal bacterial overgrowth [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par4">The liver is the front-line organ that receives and responds to gut-derived products through the portal vein, implying that the liver could be severely affected by the disrupted interaction between host and gut microbiota. Indeed, pattern-recognition receptors on Kupffer cells respond to gut-derived bacterial components like lipopolysaccharide (LPS) and contribute to local inflammation [<xref ref-type="bibr" rid="CR20">20</xref>]. Conversely, the liver also affects gut microbiota through secretion of bile, which contains bile acids and liver-derived IgA, into the intestine. A disrupted homeostasis in the gut has been reported to be associated with chronic liver diseases including primary sclerosing cholangitis, liver cirrhosis, alcoholic liver disease (ALD), and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH) [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. In this review, we will describe the IgA function on the gut microbiome and gut–liver axis, and discuss the potential role of IgA for liver diseases, especially ALD and NAFLD/NASH.</p>
</sec>
<sec id="Sec2">
<title>Secretory immunoglobulin A in the gut</title>
<sec id="Sec3">
<title>Source and function of IgA</title>
<p id="Par5">In the intestine, naïve B cells are found in the lamina propria immediately underlying the epithelium and are clustered in the gut-associated lymphoid follicles, such as the Peyer’s patches (PP). By presentation of bacterial antigens and aids from T cells in the germinal center of the gut-associated lymphoid follicles, naïve B cells are activated and become IgA-producing plasma cells. In addition, activation of B cells was found to also occur independently from T cells and specific antigens. In general, T cell-dependent IgA production is related to higher specificity and affinity to bacterial antigens than T cell-independent IgA [<xref ref-type="bibr" rid="CR23">23</xref>]. There are several extensive reviews about this B cell activation and IgA production process in the gut [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p>
<p id="Par6">IgA-producing plasma cells translocate to the lamina propria and work as a main source of the gut IgA. In the lamina propria, plasma cells produce predominantly dimeric IgA and the dimeric IgA is transcytosed across gut epithelium by a membrane receptor, pIgR that is expressed on the basolateral surface of epithelial cells. At the apical surface of epithelial cells, the IgA-pIgR complex is cleaved and IgA bound to an outer membrane part of pIgR, which is known as secretory component (SC), is released as a secretory IgA (SIgA) [<xref ref-type="bibr" rid="CR14">14</xref>]. Although SIgA produced in the lamina propria constitutes a major part of total IgA in the adult gut, there are two other sources of gut IgA: maternal milk IgA and liver-derived IgA. The milk SIgA is the only source of IgA in the gut of newborn mammals and contributes to the composition of the first gut microbiome [<xref ref-type="bibr" rid="CR26">26</xref>], instead of endogenous SIgA that starts to be produced several months after birth in humans and slowly increases [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. On the other hand, liver-derived IgA is produced by plasma cells that colonize portal regions and the submucosa of biliary tracts, and is secreted to bile by pIgR on hepatocytes and cholangiocytes [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In the human liver, however, pIgR is expressed only on cholangiocytes [<xref ref-type="bibr" rid="CR29">29</xref>]. The proportion of the liver-derived SIgA to total gut SIgA varies between species: low in human and dog, moderate in mouse, and high in rabbit and rat [<xref ref-type="bibr" rid="CR29">29</xref>]. There is a comprehensive review discussing liver IgA [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p id="Par7">Although precise mechanisms how SIgA maintains gut homeostasis and protects the host from pathogenic stimuli of bacteria are not known, several mechanisms have been suggested [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. SIgA prevents the access of bacteria to the apical surface of epithelial cells by agglutinating bacteria and/or entrapping bacteria in the mucus layer. Moreover, binding of immunoglobulins can alter gene expression of some bacteria to reduce their virulence or motility [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. In addition to direct effects on bacteria, SIgA neutralizes bacterial toxins and protects epithelial cells from the toxic stimulation [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Meanwhile SIgA binding inhibits bacterial access and invasion to epithelial cells, SIgA binding to luminal bacteria also promote sampling of the bacteria to PPs, leading to induction of a strong response against the bacteria by B and T cells [<xref ref-type="bibr" rid="CR33">33</xref>]. In general, SIgA exerts these functions without induction of deleterious inflammation at the site [<xref ref-type="bibr" rid="CR25">25</xref>]. Although precise functions of SIgA that regulate host-microbiota homeostasis in the gut are not well defined, deficiency of SIgA in mice led to altered microbiome in the gut [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>] and to increased susceptibility to both pathogens and toxic reagents [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p>
</sec>
<sec id="Sec4">
<title>IgA influence on gut microbiome and health</title>
<p id="Par8">There are several genetically modified mice which lack or have decreased SIgA in the gut lumen, and these models allow us to investigate the role of SIgA on gut homeostasis and host health. The effects of SIgA deficiency on models of infectious disease have been reviewed [<xref ref-type="bibr" rid="CR14">14</xref>]. Here, we will focus on IgA influences on gut microbiota composition and gastrointestinal infection of bacteria. <italic>Iga</italic>
<sup>−/−</sup> mice that lack the IgA switch region and the IgA constant region showed altered microbiota shift from newborn to adult [<xref ref-type="bibr" rid="CR17">17</xref>]. <italic>Iga</italic>
<sup>−/−</sup> mice showed increased and persistent colonization of Enterobacteriaceae family, which is predominant (&gt; 75%) in newborn mice and decreased (&lt; 1%) during the first 6 weeks [<xref ref-type="bibr" rid="CR17">17</xref>]. It has been reported that the Enterobacteriaceae bacteria family is increased in patients with Crohn’s disease [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], children with type 1 diabetes [<xref ref-type="bibr" rid="CR36">36</xref>], and cirrhotic patients [<xref ref-type="bibr" rid="CR21">21</xref>]. In addition, <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice exhibited sustained intestinal inflammation and increased susceptibility to dextran sodium sulfate (DSS)-induced injury [<xref ref-type="bibr" rid="CR17">17</xref>]. However, <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice showed similar susceptibility to oral infection of <italic>Citrobacter rodentium</italic> infection compared with wild-type mice [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
<p id="Par9">There are two other animal models that lack SIgA in the gut: pIgR-deficient and ‘joining’ chain (J chain)-deficient mice. These two mice cannot properly secret IgA or IgM into the gut lumen [<xref ref-type="bibr" rid="CR14">14</xref>]. Decreased abundance of <italic>Bifidobacterium</italic> spp., which are known as beneficial bacteria in general, and increased abundance of <italic>Helicobacter</italic> spp. were observed in the cecum of the <italic>Pigr</italic>
<sup>−<italic>/</italic>−</sup> mice [<xref ref-type="bibr" rid="CR38">38</xref>]. Moreover, the <italic>Pigr</italic>
<sup>−<italic>/</italic>−</sup> mice were susceptible to <italic>Salmonella typhimurium</italic> infection via the fecal–oral route [<xref ref-type="bibr" rid="CR39">39</xref>] and more vulnerable to DSS-induced colitis than wild-type mice [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. However, <italic>Pigr</italic>
<sup>−<italic>/</italic>−</sup> exhibited similar susceptibility to <italic>Citrobacter rodentium</italic> [<xref ref-type="bibr" rid="CR37">37</xref>] and <italic>Clostridium difficile</italic> as compared with wild-type mice [<xref ref-type="bibr" rid="CR40">40</xref>]. Immunized J chain-deficient mice were not protected from Cholera toxin [<xref ref-type="bibr" rid="CR41">41</xref>], while they exhibited similar clearance of <italic>Citrobacter rodentium</italic> as wild-type mice [<xref ref-type="bibr" rid="CR37">37</xref>]. There is no clear reason why these mice, lacking gut SIgA, showed normal susceptibility to several bacterial infection models. It is speculated that SIgA effects on simple bacterial infection model could be compensated by other type of immunoglobulins, such as SIgM and IgG, and/or antimicrobial peptides. Indeed, <italic>Iga</italic>
<sup>−/−</sup> mice exhibited increased SIgM level in the gut [<xref ref-type="bibr" rid="CR42">42</xref>] and mRNA of antimicrobial peptides were increased in the colon epithelium of <italic>Pigr</italic>
<sup>−/−</sup> mice [<xref ref-type="bibr" rid="CR38">38</xref>].</p>
<p id="Par10">In humans, individuals with selective IgA deficiency have a tendency to develop infections of the gastrointestinal tract (e.g.,<italic> Giardia</italic> infections), celiac disease, and inflammatory bowel diseases [<xref ref-type="bibr" rid="CR43">43</xref>]. Although selective IgA deficiency showed association with these diseases, 85–90% of IgA-deficient people are asymptomatic. However, there are few reports investigating the characteristics of gut microbiome of human IgA deficiency. Friman’s group demonstrated that IgA-deficient individuals more often had the genes involved in virulence of <italic>Escherichia coli</italic> in their rectal flora, although only several virulent factors of <italic>E. coli</italic> were examined [<xref ref-type="bibr" rid="CR44">44</xref>]. Future studies that investigate IgA-deficiency on the human gut microbiome, will be important for this field of research.</p>
</sec>
</sec>
<sec id="Sec5">
<title>IgA-microbiota on liver diseases</title>
<sec id="Sec6">
<title>Gut microbiome-liver disease</title>
<p id="Par11">Dietary factors including alcohol directly and indirectly influence the gut microbiota [<xref ref-type="bibr" rid="CR45">45</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. Intestinal bacterial overgrowth and bacterial dysbiosis after chronic alcohol consumption were observed in animals and human [<xref ref-type="bibr" rid="CR47">47</xref>]. Intragastric alcohol feeding was associated with bacterial overgrowth in the large intestine as early as 1 week after feeding in mice [<xref ref-type="bibr" rid="CR49">49</xref>]. Binge drinking of alcohol leads to elevation of blood endotoxin level. Alcohol and its metabolite acetaldehyde disrupts tight junction of epithelial cells and increase intestinal permeability [<xref ref-type="bibr" rid="CR46">46</xref>]. Mice fed with high-fat diet exhibited altered gut microbiota composition [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>] and the change was independent from obesity [<xref ref-type="bibr" rid="CR51">51</xref>], indicating high-fat diet itself influences gut microbiome composition. In addition, high-fat diet increased intestinal permeability through reduction of tight-junction proteins and induction of intestinal inflammation, leading to elevated blood endotoxin [<xref ref-type="bibr" rid="CR45">45</xref>].</p>
<p id="Par12">The mechanisms how altered gut microbiome contributes to development and progression of liver diseases were previously reviewed [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Lipopolysaccharide (LPS), known as endotoxin, is a cell-wall component of gram-negative bacteria and interacts with Toll-like receptor 4 (TLR4). As mentioned above, increased level of circulating LPS was observed in patients with ALD and rodent models of ALD [<xref ref-type="bibr" rid="CR54">54</xref>]. Increased endotoxin is also observed in alcoholic patients with minimal symptoms of ALD [<xref ref-type="bibr" rid="CR55">55</xref>] and healthy subjects with single binge drinking [<xref ref-type="bibr" rid="CR56">56</xref>]. In addition, the LPS levels correlate with disease severity [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. In mice, a LPS increase was observed both by acute binge gavage and chronic feeding with ethanol [<xref ref-type="bibr" rid="CR59">59</xref>]. In addition to LPS, other bacterial components, such as bacterial 16S DNA and peptidoglycan which is a cell-wall component of gram-positive bacteria, were also increased in the circulating blood [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. In general, liver-resident macrophages, Kupffer cells, are tolerant to LPS-induced TLR4 activation and eliminate microbial components without inflammatory response. However, prolonged and excessive exposure to LPS can make Kupffer cells sensitive to LPS [<xref ref-type="bibr" rid="CR20">20</xref>]. Moreover, ethanol-induced hepatocyte damage is associated with the liver macrophage activation through the damage associated molecular pattern production or signaling molecule-containing exosome production [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Thus, sensitized Kupffer cells by ethanol-stimulated hepatocytes respond to gut-derived bacterial and fungal components and promote local inflammation in the liver. Other types of microbial products that are derived from the gut, such as bacterial DNA and cell-wall components, are also possible mediators of liver inflammation [<xref ref-type="bibr" rid="CR20">20</xref>]. Recently, we found 1,3-β-glucan, which is a cell-wall component of fungi, is also increased in alcohol-fed mice and anti-<italic>Saccharomyces cerevisiae</italic> IgG antibody is significantly higher in alcoholic cirrhosis patients than in healthy individuals or viral cirrhosis patients [<xref ref-type="bibr" rid="CR63">63</xref>]. Translocating fungi cell-wall component promoted IL-1β processing and local inflammation via its receptor, dectin-1, on liver macrophage cells [<xref ref-type="bibr" rid="CR63">63</xref>].</p>
<p id="Par13">Diet-induced endotoxemia is observed in rodent models of obesity and NAFLD/NASH [<xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. In humans, NAFLD/NASH patients have higher level of systemic endotoxin when compared with healthy people [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Infiltration of LPS into the liver has been shown to exacerbate liver injury in NAFLD/NASH mice, possibly via TLR4 activation [<xref ref-type="bibr" rid="CR70">70</xref>]. Predisposition to obesity, which is a common factor attributed to NAFLD/NASH development, has been shown to be influenced by gut microbiota [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. Germ-free mice, which do not have any microorganisms in their body, are tolerant to high-fat diet-induced weight gain. By transplantation of gut microbiota from obese mice, but not from lean mice, germ-free mice gained more fat by high-fat diet [<xref ref-type="bibr" rid="CR73">73</xref>]. That could be mediated by increased energy extraction from diet via altered microbiome. In addition, the production of fasting-induced adipocyte factor (Fiaf) is suppressed by enteric bacteria, resulting in increased activity of lipoprotein lipase and increased accumulation of triglycerides in the liver [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. High-fat diet altered microbiota composition toward metabolizing dietary choline to methylamines, resulting in reduced level of plasma phosphatidylcholine [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Choline-deficient diet, which also reduces phosphatidylcholine, is used to create rodent model of NASH. Reduced level of phosphatidylcholine, which is necessary for assembly of very-low-density lipoprotein (VLDL), results in triglyceride accumulation in the liver [<xref ref-type="bibr" rid="CR21">21</xref>]. In addition, obese patients and children with NASH showed increased blood ethanol concentration [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Increased ethanol produced by altered gut microbiome could possibly be a mediator of liver damage [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR52">52</xref>].</p>
</sec>
<sec id="Sec7">
<title>The role of IgA in NAFLD/NASH and ALD</title>
<p id="Par14">IgA has been studied in the field of alcoholic liver disease for a long time [<xref ref-type="bibr" rid="CR76">76</xref>]. Brown and Kloppel reviewed IgA levels in serum and the liver of ALD patients [<xref ref-type="bibr" rid="CR29">29</xref>]. Systemic IgA levels are increased in patients with alcoholic liver disease [<xref ref-type="bibr" rid="CR29">29</xref>] and in a rodent model of alcoholic liver disease [<xref ref-type="bibr" rid="CR77">77</xref>]. In addition, liver IgA deposits appear specific for alcoholic liver disease, correlate with the amount of alcohol consumption, but not with serum IgA concentrations [<xref ref-type="bibr" rid="CR78">78</xref>–<xref ref-type="bibr" rid="CR80">80</xref>]. Moro-Sibilot and colleagues demonstrated that mouse and human liver contain IgA-secreting cells. Increased amount of IgA-secreting cells in mice fed with ethanol was diminished by inhibition of IgA-plasmablast egress from Peyer’s Patches with FTY720 that modulates sphingosine-1-phosphate receptor 1 and inhibits the egress of lymphocytes form secondary lymphoid organs, indicating that IgA deposits in the liver of ALD patients is attributed, at least partially, to increased entry of IgA-secreting cells from Peyer’s Patches to the liver [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p id="Par15">SIgA levels in the gut of chronic liver diseases seems more important than systemic and liver IgA changes because SIgA regulates gut homeostasis. Studies that examined IgA levels in the gut of alcoholic patients and rodent models of ALD and NAFLD/NASH are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>. The number of IgA-secreting plasma cells in the intestinal lamina propria [<xref ref-type="bibr" rid="CR30">30</xref>] and fecal IgA levels [<xref ref-type="bibr" rid="CR77">77</xref>], which reflect the amount of colonic IgA, are reduced in experimental models of ethanol-induced liver disease of mice. These decreased SIgA and/or IgA-secreting cells in the intestine are reproducibly observed in rodent models of chronic alcohol feeding [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>], but not in rat model of single administration with ethanol [<xref ref-type="bibr" rid="CR83">83</xref>–<xref ref-type="bibr" rid="CR85">85</xref>]. Studies investigating intestinal IgA of patients with alcoholics are very limited [<xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR88">88</xref>]. Pelletier et al. observed decreased intestinal secretion of SIgA in patients with severe alcoholic cirrhosis when compared to patients with compensated alcoholic cirrhosis [<xref ref-type="bibr" rid="CR86">86</xref>]. In contrast, Colombel et al. showed similar levels of jejunal SIgA secretion among alcoholics with cirrhosis, alcoholics without cirrhosis, and control subjects [<xref ref-type="bibr" rid="CR87">87</xref>]. Maier and colleagues observed similar number of IgA-secreting cells in duodenum between alcoholics and controls, but a slightly decreased IgA amount in IgA-secreting cells of alcoholics with recent alcohol intake [<xref ref-type="bibr" rid="CR88">88</xref>]. These conflicting reports may result from subjects in different stages of the disease or different methods of IgA measurement. Recently, we investigated the role of IgA in a mouse model of ethanol-induced liver disease by using <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice. Unexpectedly, <italic>Iga</italic>
<sup>−/−</sup> mice fed with ethanol showed similar degrees of liver injury (plasma ALT), hepatic triglyceride accumulation, and liver inflammation as compared with wile-type littermates [<xref ref-type="bibr" rid="CR77">77</xref>]. Interestingly, we observed increased bacterial translocation to mesenteric lymph node in <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice fed with control diet, but no further increase of the translocation in <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice fed with ethanol. The result suggests that exposure of the liver of <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice to gut-derived bacterial component is increased under physiological conditions and the increased translocation is further regulated by other factors than SIgA during disease. One possible reason why loss of IgA did not affect disease development is a compensation by SIgM. The <italic>Iga</italic>
<sup>−/−</sup> mice fed with ethanol exhibited increased level of fecal IgM [<xref ref-type="bibr" rid="CR77">77</xref>]. Further studies investigating compensatory roles of intestinal IgM and/or antimicrobial peptides are necessary.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Changes in intestinal IgA associated with ALD and NAFLD/NASH in human and rodents</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Human disease/animal model</th><th align="left">Subjects</th><th align="left">IgA (tissue)</th><th align="left">IgA level</th><th align="left">References</th></tr></thead><tbody><tr><td align="left" colspan="5">Human, alcoholics</td></tr><tr><td align="left"> Alcoholic cirrhosis</td><td align="left">Severe cirrhosis with jaundice, compensated cirrhosis, and control</td><td align="left">Monomeric IgA and SIgA (perfusion fluid of proximal small intestine)</td><td align="left">Severe cirrhosis &lt; compensated cirrhosis = control</td><td align="left">[<xref ref-type="bibr" rid="CR86">86</xref>]</td></tr><tr><td align="left"> Alcoholics</td><td align="left">Alcoholics with cirrhosis, alcoholics without cirrhosis, and control</td><td align="left">SIgA (perfusion fluid of jejunum)</td><td align="left">Alcoholics with/without cirrhosis = control</td><td align="left">[<xref ref-type="bibr" rid="CR87">87</xref>]</td></tr><tr><td align="left"> Alcoholics</td><td align="left">Alcoholics with recent drink, alcoholics without recent drink, and control</td><td align="left">Number of IgA plasma cells (duodenum)</td><td align="left">Alcoholics = control</td><td align="left">[<xref ref-type="bibr" rid="CR88">88</xref>]</td></tr><tr><td align="left"></td><td align="left"></td><td align="left">Amount of IgA in IgA plasma cell (duodenum)</td><td align="left">Alcoholics with recent drink &lt;= alcoholics without recent drink and control</td><td align="left"></td></tr><tr><td align="left" colspan="5">Animal, ALD</td></tr><tr><td align="left"> Wister rat, female</td><td align="left">Intraperitoneal injection of ethanol (4 g/kg) for 30 min</td><td align="left">IgA-positive cells (Peyer’s patch and lamina propria of small intestine)</td><td align="left">EtOH &gt; saline in lamina propria, EtOH = control in Peyer’s patch</td><td align="left">[<xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td align="left"> Wister rat, female</td><td align="left">Intraperitoneal injection of ethanol (4 g/kg) for 30 min, ± treatment with NOS inhibitor</td><td align="left">IgA-positive cells (ileal lamina propria)</td><td align="left">EtOH &gt; EtOH + inhibitor = saline</td><td align="left">[<xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td align="left"> Wister rat, male</td><td align="left">Intraperitoneal injection of ethanol (4 g/kg) for 30 min, ± treatment with neuronal NOS inhibitor</td><td align="left">SIgA (ileal extract)</td><td align="left">EtOH &gt; EtOH + inhibitor = saline</td><td align="left">[<xref ref-type="bibr" rid="CR83">83</xref>]</td></tr><tr><td align="left"> Wister rat, male</td><td align="left">Lieber-DeCarli liquid diet for 4 weeks</td><td align="left">IgA-positive cells (jejunal and colonic mucosa)</td><td align="left">EtOH &lt; control</td><td align="left">[<xref ref-type="bibr" rid="CR81">81</xref>]</td></tr><tr><td align="left"> C57BL/6 mouse, female</td><td align="left">Lieber-DeCarli liquid diet for 8 weeks</td><td align="left">SIgA (feces)</td><td align="left">EtOH &lt; control</td><td align="left">[<xref ref-type="bibr" rid="CR77">77</xref>]</td></tr><tr><td align="left"> C57BL/6-Ly5.1 mouse</td><td align="left">Lieber-DeCarli liquid diet for 10 days + binge (5 g/kg) for 9 h</td><td align="left">IgA-positive plasma cells (small intestinal lamina propria)</td><td align="left">EtOH &lt; control</td><td align="left">[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left"> C57BL/6 mouse</td><td align="left">20% w/v ethanol in drinking water for 10-12 weeks</td><td align="left">SIgA (contents of small and large intestine)</td><td align="left">EtOH &lt; control</td><td align="left">[<xref ref-type="bibr" rid="CR82">82</xref>]</td></tr><tr><td align="left" colspan="5">Animal, NAFLD/NASH</td></tr><tr><td align="left"> Sprague–Dawley rat, female</td><td align="left">High-fat diet (88% normal + 10% lard + 2% cholesterol) for 8-12 weeks</td><td align="left">SIgA (small intestinal mucosa)</td><td align="left">HF = &lt; control in 8 weeks, HF &lt; control at 12 weeks</td><td align="left">[<xref ref-type="bibr" rid="CR95">95</xref>]</td></tr><tr><td align="left"> Sprague–Dawley rat, male</td><td align="left">High-fat diet (30% w/w beef tallow) for 3 weeks, ± supplied with curcumin</td><td align="left">SIgA (feces)</td><td align="left">HF + curcumin &gt; HF &gt; LF + curcumin = LF</td><td align="left">[<xref ref-type="bibr" rid="CR92">92</xref>]</td></tr><tr><td align="left"> Sprague–Dawley rat, male</td><td align="left">High-fat diet (30% w/w beef tallow) for 3 weeks, ± supplied with sericin</td><td align="left">SIgA (feces and colon)</td><td align="left">HF + sericin &gt; HF = LF = LF + sericin in feces</td><td align="left">[<xref ref-type="bibr" rid="CR93">93</xref>]</td></tr><tr><td align="left"></td><td align="left"></td><td align="left"></td><td align="left">HF + sericin = LF + sericin &gt; HF = LF</td><td align="left"></td></tr><tr><td align="left"> Sprague–Dawley rat</td><td align="left">High-fat diet (60% fat energy) for 8 weeks, ± supplied with polyphenols</td><td align="left">SIgA (feces)</td><td align="left">HF + polyphenols &gt; HF = LF</td><td align="left">[<xref ref-type="bibr" rid="CR96">96</xref>]</td></tr><tr><td align="left"> C57BL/6 mouse, male</td><td align="left">Methionine-choline-deficient diet for 3 weeks, ± supplied with fructo-oligosaccharide</td><td align="left">SIgA (feces), IgA-positive cells (ileum and colon)</td><td align="left">MCD &lt; control &lt; MCD + fructo-origosaccharide (SIgA and IgA-positive cells)</td><td align="left">[<xref ref-type="bibr" rid="CR94">94</xref>]</td></tr></tbody></table><table-wrap-foot><p>
<italic>SIgA</italic> secretory IgA, <italic>EtOH</italic> ethanol, <italic>HF</italic> high-fat diet, <italic>LF</italic> low-fat diet, <italic>MCD</italic> methionine-choline-deficient diet, <italic>NOS</italic> nitric oxide synthase</p></table-wrap-foot></table-wrap>
</p>
<p id="Par16">Unlike the case of ALD, reports that investigated an association between serum IgA level and NAFLD/NASH are limited [<xref ref-type="bibr" rid="CR89">89</xref>–<xref ref-type="bibr" rid="CR91">91</xref>]. Tomita et al. showed that serum IgA concentration is increased in severe-NASH patients when compared with early-stage NASH patients, although IgA concentrations were comparable among control, simple steatosis, NAFLD, and early-stage NASH [<xref ref-type="bibr" rid="CR89">89</xref>]. McPherson’s group showed that serum IgA was elevated in NASH patients as compared with simple steatosis patients [<xref ref-type="bibr" rid="CR90">90</xref>]. In these studies, serum IgA levels were positively associated with severity of liver fibrosis [<xref ref-type="bibr" rid="CR89">89</xref>–<xref ref-type="bibr" rid="CR91">91</xref>]. However, associations between increased serum IgA and advanced stage are also observed in other types of chronic liver diseases. Thus, increased systemic IgA levels in NAFLD/NASH patients may not be a specific marker for the disease progression. Although there is no study that investigated intestinal or fecal IgA levels of NAFLD/NASH patients, several studies using rodent models of NAFLD/NASH showed altered intestinal IgA secretion [<xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR96">96</xref>]. In the study of Matsumoto’s group, mice with NASH induced by methionine-choline-deficient diet, exhibited decreased fecal IgA and IgA-positive cells in ileal and colonic tissues [<xref ref-type="bibr" rid="CR94">94</xref>]. In addition, Li et al. showed decreased IgA in small intestinal mucosa of rats fed with high-fat diet, and a negative correlation between the intestinal IgA levels and systemic endotoxin levels [<xref ref-type="bibr" rid="CR95">95</xref>]. However, similar IgA levels of feces between high-fat and control groups or increased fecal IgA in high-fat group were observed in several studies [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. Different feeding protocol might explain these results. In the study from Li’s group, decreased SIgA in the small intestine was not observe in 8-week feeding group, but observed in 12-week feeding group [<xref ref-type="bibr" rid="CR95">95</xref>]. Although the mechanisms how increased systemic IgA and/or reduced intestinal SIgA are involved in disease development and progression are not clear yet, some gut dysbiosis and bacterial overgrowth observed in ALD and NAFLD/NASH might contribute to decreased SIgA levels in the gut.</p>
</sec>
<sec id="Sec8">
<title>The role of SIgA on gut microbiome in NAFLD/NASH and ALD</title>
<p id="Par17">The study of gut SIgA functions in liver diseases is the field that started recently, and SIgA behavior in the gut of human alcoholic patients has not been intensively investigated yet. However, several studies revealed shared features of gut microbiome changes between SIgA-deficient mice and human patients with alcoholic liver disease. As mentioned above, <italic>Iga</italic>
<sup>−<italic>/</italic>−</sup> mice exhibited increased colonization of Enterobacteriaceae family (in phylum Proteobacteria) [<xref ref-type="bibr" rid="CR17">17</xref>]. Increased abundance of phylum Proteobacteria is a signature of intestinal dysbiosis associated with metabolic and inflammatory diseases [<xref ref-type="bibr" rid="CR97">97</xref>]. Moon et al. found dichotomous fecal IgA levels among wild-type mice in the same facility and the IgA-low phenotype was driven by transmissible fecal bacteria [<xref ref-type="bibr" rid="CR98">98</xref>]. This IgA-low phenotype of mice was associated with enriched Enterobacteriaceae family. Although increased Enterobacteriaceae family was not observed in IgA-low mice from a different facility in the same study, the phylum Proteobacteria was increased in the mice [<xref ref-type="bibr" rid="CR98">98</xref>]. These results indicate decreased SIgA may drive the expansion of Enterobacteriaceae family (or phylum Proteobacteria) in the gut of chronic liver diseases, such as ALD and NAFLD/NASH. Increased members of the Enterobacteriaceae family or phylum Proteobacteria is also observed in chronic liver diseases [<xref ref-type="bibr" rid="CR21">21</xref>]. Zhu et al. and colleagues revealed that abundance of <italic>Escherichia</italic> spp. (in Enterobacteriaceae family) and Enterobacteriaceae family are increased in stool of children with NASH when compared with healthy children or children with obesity [<xref ref-type="bibr" rid="CR10">10</xref>]. Increased <italic>Gammmaproteobacteria</italic> class, which includes Enterobacteriaceae family, was also observed in children with NAFLD when compared with healthy children in a different study [<xref ref-type="bibr" rid="CR99">99</xref>]. A study in which gut microbiota composition were compared between 53 NAFLD patients and 32 healthy subjects showed increased <italic>Escherichia</italic> spp. in NAFLD patients [<xref ref-type="bibr" rid="CR100">100</xref>]. Increased abundance of phylum Proteobacteria and/or Enterobacteriaceae family were reproduced in rodent models of NAFLD [<xref ref-type="bibr" rid="CR101">101</xref>–<xref ref-type="bibr" rid="CR104">104</xref>]. However, the enrichment of Enterobacteriaceae and <italic>Escherichia</italic> spp. was not reproduced in human studies [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. Taken together, decreased amount of SIgA in the gut lumen, which was observed in rats fed with high-fat diet [<xref ref-type="bibr" rid="CR95">95</xref>], may contribute to expansion of phylum Proteobacteria and/or Enterobacteriaceae family of bacteria and disease pathogenesis.</p>
<p id="Par18">The prominent feature of dysbiosis observed in alcoholic patients and rodent model of alcoholic liver disease is characterized by a decreased phylum Firmicutes and lower amount of <italic>Lactobacillus</italic> spp. (in phylum Firmicutes) [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR107">107</xref>–<xref ref-type="bibr" rid="CR110">110</xref>]. Probiotic treatment with <italic>Lactobacillus</italic> spp. and <italic>Bifidobacterium</italic> spp. improved bacterial dysbiosis and ameliorated liver injury and/or inflammation in both humans and animal models (previously reviewed by Bluemel et al. [<xref ref-type="bibr" rid="CR111">111</xref>]). In addition to these bacteria, alcoholic patients with dysbiosis showed a higher relative abundance of <italic>Gammmaproteobacteria</italic> class (in phylum Proteobacteria) than alcoholic patients without dysbiosis [<xref ref-type="bibr" rid="CR112">112</xref>]. Relative abundance of Enterobacteriaceae family was higher in the stool of patients with alcohol hepatitis than alcoholic patients without hepatitis [<xref ref-type="bibr" rid="CR113">113</xref>]. Increased Enterobacteriaceae is reproducibly observed in human cirrhotic patients [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]. Bajaj et al. proposed the cirrhosis dysbiosis ratio (CDR). The ratio of “good” bacteria, such as <italic>Lactobacillus</italic> spp., against potentially “bad” bacteria, such as Enterobacteriaceae was lower in advanced cirrhotic patients as compared with that in compensated-cirrhotic patients [<xref ref-type="bibr" rid="CR58">58</xref>]. Especially, cirrhotic patients with alcoholic etiology showed increased Enterobacteriaceae family [<xref ref-type="bibr" rid="CR58">58</xref>]. Although these facts suggest a possible link between reduced SIgA and development of the disease, studies investing direct effects of SIgA on the diseases are limited. Further studies investigating the change of gut microbiome and disease status in SIgA-deficient mice are required.</p>
</sec>
</sec>
<sec id="Sec9">
<title>Fc receptor alpha I and IgA on liver diseases</title>
<p id="Par19">In addition to the SIgA roles in the intestinal lumen, it has been suggested that serum and lamina propria IgA play a role in mucosal immunity via binding to a transmembrane receptor, Fc receptor alpha I (FcαRI) [<xref ref-type="bibr" rid="CR115">115</xref>]. Functions of FcαRI are previously reviewed [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. FcαRI is expressed on cells of the myeloid lineage, including neutrophils, eosinophils, and Kupffer cells [<xref ref-type="bibr" rid="CR116">116</xref>]. In contrast to non-inflammatory functions of SIgA, serum monomeric IgA and dimeric IgA (dIgA) in the lamina propria can induce several pro-inflammatory functions via the binding to FcαRI [<xref ref-type="bibr" rid="CR115">115</xref>]. Cross-linking of FcαRI by IgA immune complexes (e.g., IgA-coated bacterial cells) mediates the production of reactive oxygen species and lymphokine from neutrophils and promotes phagocytosis by neutrophils and Kupffer cells [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. However, studies investigating this topic are lacking, because mice do not have an equivalent receptor of the human FcαRI [<xref ref-type="bibr" rid="CR118">118</xref>].</p>
<p id="Par20">Egmond’s group revealed serum IgA to eliminate bacteria invading the liver, by using mice with a transgene that is introduced with a cosmid clone containing the human FcαRI gene [<xref ref-type="bibr" rid="CR117">117</xref>]. Kupffer cells that express the human FcαRI effectively phagocytosed bacteria coated with serum IgA, but not with SIgA. In contrast, the number of phagocytosed bacteria in the liver of non-transgenic mice were only 20% of that of the transgenic mice [<xref ref-type="bibr" rid="CR117">117</xref>]. In addition, neutrophils isolated from healthy human donors responded to serum IgA and produce leukotriene B4 (LTB4), leading to further recruitment of neutrophils [<xref ref-type="bibr" rid="CR119">119</xref>]. Mouse neutrophils that express human FcαRI phagocytosed IgA-coated bacteria more than BSA-coated bacteria. In the colon of patients with ulcerative colitis, a number of FcαRI-expressing neutrophils infiltrated the lamina propria and phagocytosed IgA-complexes. In contrast, few neutrophils were observed in the colon of healthy subjects [<xref ref-type="bibr" rid="CR119">119</xref>]. These results indicate that IgA opsonizes bacteria and promotes effective phagocytosis of and elimination of the invading bacteria via binding to FcαRI on phagocytes. Thus, serum IgA and lamina propria dIgA can work as second line barrier against translocated bacteria from the gut lumen to lamina propria, portal blood, and the liver which is observed in patients with ALD and NAFLD/NASH. However, excessive activation of this function potentially can lead to local inflammation. There is no study investigating the role and expression of FcαRI in the liver and/or gut of patients with ALD and NAFLD/NASH and of animal models. These studies are necessary to understand the precise role of IgA on pathogenesis of diseases.</p>
</sec>
<sec id="Sec10">
<title>Future directions</title>
<p id="Par21">The intestinal microbiome has been suggested to contribute to the development and progression of ALD and NAFLD/NASH. However, precise mechanisms how the gut microbiome contributes to the disease pathogenesis and how the development of diseases disrupts gut homeostasis are not fully understood. Some features of altered gut microbiome, such as increased phylum Proteobacteria and Enterobacteriaceae family of bacteria, are shared between IgA-deficient animals and patients with and animal models of ALD and NAFLD/NASH. In addition, chronic feeding of alcohol and an obesogenic diet causing NAFLD/NASH led to decreased intestinal production of IgA in rodents. These facts imply the potential role of SIgA on the liver diseases. However, there are limited studies that investigate SIgA change in patients and reveal direct influence of IgA-deficiency on development of ALD, NAFLD or NASH. These studies are necessary in the future.</p>
<p id="Par22">In addition to SIgA in the gut homeostasis, the role of circulating IgA, which is increased in ALD and NASH with cirrhosis, also requires to be investigated in future studies. It has been suggested that FcαRI on Kupffer cells and neutrophils contribute to elimination of gut-derived bacteria and its products via activating phagocytosis. However, it has been difficult to investigate the role of IgA-FcαRI in development of the liver diseases because mice lack equivalent receptor of human FcαRI. To apply the transgenic mice introduced with the human FcαRI gene to investigate the role could be a solution of the problem.
</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This work was supported in part by JSPS Grant-in-Aid for Young Scientists (B) 17K15953 (to TI) and NIH Grants R01 AA020703, U01 AA24726 and U01 AA021856 (to BS) and by Award I01BX002213 from the Biomedical Laboratory Research and Development Service of the VA Office of Research and Development (to BS).</p>
</ack>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p id="Par23">There is no conflict of interest.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>St Amand</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2007</year>
<volume>104</volume>
<fpage>13780</fpage>
<lpage>13785</lpage>
<pub-id pub-id-type="pmid">17699621</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willing</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Dicksved</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Halfvarson</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes</article-title>
<source/>Gastroenterology
          <year>2010</year>
<volume>139</volume>
<issue>1844–1854</issue>
<fpage>e1</fpage>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A core gut microbiome in obese and lean twins</article-title>
<source/>Nature
          <year>2009</year>
<volume>457</volume>
<fpage>480</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="pmid">19043404</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Chatelier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
<source/>Nature
          <year>2013</year>
<volume>500</volume>
<fpage>541</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="pmid">23985870</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>
<source/>Nature
          <year>2012</year>
<volume>490</volume>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">23023125</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Tremaroli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nookaew</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut metagenome in European women with normal, impaired and diabetic glucose control</article-title>
<source/>Nature
          <year>2013</year>
<volume>498</volume>
<fpage>99</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">23719380</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsiao</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Hsien</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<fpage>1451</fpage>
<lpage>1463</lpage>
<pub-id pub-id-type="pmid">24315484</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>D-W</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>ZE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reduced incidence of prevotella and other fermenters in intestinal microflora of autistic children</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e68322</fpage>
<pub-id pub-id-type="pmid">23844187</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of fecal microbial communities in patients with liver cirrhosis</article-title>
<source/>Hepatology
          <year>2011</year>
<volume>54</volume>
<fpage>562</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="pmid">21574172</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH</article-title>
<source/>Hepatology
          <year>2013</year>
<volume>57</volume>
<fpage>601</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="pmid">23055155</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajaj</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Ridlon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hylemon</surname>
<given-names>PB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linkage of gut microbiome with cognition in hepatic encephalopathy</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2012</year>
<volume>302</volume>
<fpage>G168</fpage>
<lpage>G175</lpage>
<pub-id pub-id-type="pmid">21940902</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hooper</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Macpherson</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Immune adaptations that maintain homeostasis with the intestinal microbiota</article-title>
<source/>Nat Rev Immunol
          <year>2010</year>
<volume>10</volume>
<fpage>159</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="pmid">20182457</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conley</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Delacroix</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense?</article-title>
<source/>Ann Intern Med
          <year>1987</year>
<volume>106</volume>
<fpage>892</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="pmid">3579073</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strugnell</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wijburg</surname>
<given-names>OLC</given-names>
</name>
</person-group>
<article-title>The role of secretory antibodies in infection immunity</article-title>
<source/>Nat Rev Microbiol
          <year>2010</year>
<volume>8</volume>
<fpage>656</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="pmid">20694027</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantis</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Rol</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Corthésy</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut</article-title>
<source/>Mucosal Immunol
          <year>2011</year>
<volume>4</volume>
<fpage>603</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="pmid">21975936</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubinak</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Round</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Do antibodies select a healthy microbiota?</article-title>
<source/>Nat Rev Immunol
          <year>2016</year>
<volume>16</volume>
<fpage>767</fpage>
<lpage>774</lpage>
<pub-id pub-id-type="pmid">27818504</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirpuri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Raetz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sturge</surname>
<given-names>CR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Proteobacteria-specific IgA regulates maturation of the intestinal microbiota</article-title>
<source/>Gut Microbes.
          <year>2014</year>
<volume>5</volume>
<fpage>28</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">24637807</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Meek</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Doi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2004</year>
<volume>101</volume>
<fpage>1981</fpage>
<lpage>1986</lpage>
<pub-id pub-id-type="pmid">14766966</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shinkura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Doi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense</article-title>
<source/>Nat Immunol
          <year>2011</year>
<volume>12</volume>
<fpage>264</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="pmid">21258321</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Petrasek</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Gut-liver axis and sterile signals in the development of alcoholic liver disease</article-title>
<source/>Alcohol Alcohol
          <year>2017</year>
<volume>52</volume>
<fpage>414</fpage>
<lpage>424</lpage>
<pub-id pub-id-type="pmid">28482064</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schnabl</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Interactions between the intestinal microbiome and liver diseases</article-title>
<source/>Gastroenterology
          <year>2014</year>
<volume>146</volume>
<fpage>1513</fpage>
<lpage>1524</lpage>
<pub-id pub-id-type="pmid">24440671</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tilg</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>EA</given-names>
</name>
</person-group>
<source/>Gut microbiome and liver diseases. Gut.
          <year>2016</year>
<volume>65</volume>
<fpage>2035</fpage>
<lpage>2044</lpage>
<pub-id pub-id-type="pmid">27802157</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Littman</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>The microbiota in adaptive immune homeostasis and disease</article-title>
<source/>Nature
          <year>2016</year>
<volume>535</volume>
<fpage>75</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">27383982</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fagarasan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kawamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kanagawa</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis</article-title>
<source/>Annu Rev Immunol
          <year>2010</year>
<volume>28</volume>
<fpage>243</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="pmid">20192805</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutzeit</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Magri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cerutti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Intestinal IgA production and its role in host-microbe interaction</article-title>
<source/>Immunol Rev
          <year>2014</year>
<volume>260</volume>
<fpage>76</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">24942683</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogier</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Frantz</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>MEC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2014</year>
<volume>111</volume>
<fpage>3074</fpage>
<lpage>3079</lpage>
<pub-id pub-id-type="pmid">24569806</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pabst</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Cerovic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hornef</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Secretory IgA in the coordination of establishment and maintenance of the microbiota</article-title>
<source/>Trends Immunol
          <year>2016</year>
<volume>37</volume>
<fpage>287</fpage>
<lpage>296</lpage>
<pub-id pub-id-type="pmid">27066758</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weemaes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klasen</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Goertz</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Development of immunoglobulin A in infancy and childhood</article-title>
<source/>Scand J Immunol
          <year>2003</year>
<volume>58</volume>
<fpage>642</fpage>
<lpage>648</lpage>
<pub-id pub-id-type="pmid">14636420</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Kloppel</surname>
<given-names>TM</given-names>
</name>
</person-group>
<article-title>The liver and IgA: immunological, cell biological and clinical implications</article-title>
<source/>Hepatology
          <year>1989</year>
<volume>9</volume>
<fpage>763</fpage>
<lpage>784</lpage>
<pub-id pub-id-type="pmid">2651270</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moro-Sibilot</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Blanc</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Taillardet</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mouse and human liver contain immunoglobulin A—secreting cells originating from Peyer’s patches and directed against intestinal antigens</article-title>
<source/>Gastroenterology
          <year>2016</year>
<volume>151</volume>
<fpage>311</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">27132185</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>McNulty</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Guruge</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>IgA response to symbiotic bacteria as a mediator of gut homeostasis</article-title>
<source/>Cell Host Microbe
          <year>2007</year>
<volume>2</volume>
<fpage>328</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="pmid">18005754</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cullender</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Chassaing</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Janzon</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut</article-title>
<source/>Cell Host Microbe
          <year>2013</year>
<volume>14</volume>
<fpage>571</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="pmid">24237702</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fransen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zagato</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mazzini</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity</article-title>
<source/>Immunity
          <year>2015</year>
<volume>43</volume>
<fpage>527</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="pmid">26362264</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murthy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Dubose</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Banas</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis</article-title>
<source/>J Gastroenterol Hepatol
          <year>2006</year>
<volume>21</volume>
<fpage>1372</fpage>
<lpage>1380</lpage>
<pub-id pub-id-type="pmid">16911679</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gevers</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kugathasan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denson</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The treatment-naive microbiome in new-onset Crohn’s disease</article-title>
<source/>Cell Host Microbe
          <year>2014</year>
<volume>15</volume>
<fpage>382</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="pmid">24629344</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soyucen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gulcan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aktuglu-Zeybek</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differences in the gut microbiota of healthy children and those with type 1 diabetes</article-title>
<source/>Pediatr Int
          <year>2014</year>
<volume>56</volume>
<fpage>336</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="pmid">24475780</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maaser</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Housley</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Iimura</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clearance of <italic>Citrobacter rodentium</italic> requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies</article-title>
<source/>Infect Immun
          <year>2004</year>
<volume>72</volume>
<fpage>3315</fpage>
<lpage>3324</lpage>
<pub-id pub-id-type="pmid">15155635</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reikvam</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Derrien</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice</article-title>
<source/>Eur J Immunol
          <year>2012</year>
<volume>42</volume>
<fpage>2959</fpage>
<lpage>2970</lpage>
<pub-id pub-id-type="pmid">22865203</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wijburg</surname>
<given-names>OLC</given-names>
</name>
<name>
<surname>Uren</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Simpfendorfer</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Innate secretory antibodies protect against natural<italic> Salmonella typhimurium</italic> infection</article-title>
<source/>J Exp Med
          <year>2006</year>
<volume>203</volume>
<fpage>21</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">16390940</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Gerding</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Protection from<italic> Clostridium difficile</italic> infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice</article-title>
<source/>Infect Immun
          <year>2014</year>
<volume>82</volume>
<fpage>522</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="pmid">24478068</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lycke</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Erlandsson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ekman</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection</article-title>
<source/>J Immunol.
          <year>1999</year>
<volume>163</volume>
<fpage>913</fpage>
<lpage>919</lpage>
<pub-id pub-id-type="pmid">10395687</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harriman</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Bogue</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes</article-title>
<source/>J Immunol.
          <year>1999</year>
<volume>162</volume>
<fpage>2521</fpage>
<lpage>2529</lpage>
<pub-id pub-id-type="pmid">10072491</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yel</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Selective IgA Deficiency</article-title>
<source/>J Clin Immunol
          <year>2010</year>
<volume>30</volume>
<fpage>10</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">20101521</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friman</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nowrouzian</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Adlerberth</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased frequency of intestinal<italic> Escherichia coli</italic> carrying genes for S fimbriae and haemolysin in IgA-deficient individuals</article-title>
<source/>Microb Pathog
          <year>2002</year>
<volume>32</volume>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="pmid">11782119</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirpich</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Marsano</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>McClain</surname>
<given-names>CJ</given-names>
</name>
<collab>The Canadian Society of Clinical Chemists</collab>
</person-group>
<article-title>Gut–liver axis, nutrition, and non-alcoholic fatty liver disease</article-title>
<source/>Clin Biochem.
          <year>2015</year>
<volume>48</volume>
<fpage>923</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">26151226</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Gut–liver axis in alcoholic liver disease</article-title>
<source/>Gastroenterology
          <year>2015</year>
<volume>148</volume>
<fpage>30</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">25447847</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Seebauer</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Schnabl</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Alcoholic liver disease: the gut microbiome and liver cross talk</article-title>
<source/>Alcohol Clin Exp Res
          <year>2015</year>
<volume>39</volume>
<fpage>763</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="pmid">25872593</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leung</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Furness</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of the gut microbiota in NAFLD</article-title>
<source/>Nat Rev Gastroenterol Hepatol.
          <year>2016</year>
<volume>13</volume>
<fpage>412</fpage>
<lpage>425</lpage>
<pub-id pub-id-type="pmid">27273168</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice</article-title>
<source/>Hepatology
          <year>2013</year>
<volume>58</volume>
<fpage>108</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="pmid">23408358</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Neyrinck</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Fava</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia</article-title>
<source/>Diabetologia
          <year>2007</year>
<volume>50</volume>
<fpage>2374</fpage>
<lpage>2383</lpage>
<pub-id pub-id-type="pmid">17823788</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrandt</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sherrill-Mix</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-fat diet determines the composition of the murine gut microbiome independently of obesity</article-title>
<source/>Gastroenterology
          <year>2009</year>
<volume>137</volume>
<issue>1716–1724</issue>
<fpage>e2</fpage>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llorente</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schnabl</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The gut microbiota and liver disease</article-title>
<source/>Cell Mol Gastroenterol Hepatol.
          <year>2015</year>
<volume>1</volume>
<fpage>275</fpage>
<lpage>284</lpage>
<pub-id pub-id-type="pmid">26090511</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W-C</given-names>
</name>
<name>
<surname>Schnabl</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease</article-title>
<source/>Front Physiol.
          <year>2012</year>
<volume>3</volume>
<fpage>402</fpage>
<pub-id pub-id-type="pmid">23087650</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Endotoxemia and gut barrier dysfunction in alcoholic liver disease</article-title>
<source/>Hepatology
          <year>2009</year>
<volume>50</volume>
<fpage>638</fpage>
<lpage>644</lpage>
<pub-id pub-id-type="pmid">19575462</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schäfer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Parlesak</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schütt</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease</article-title>
<source/>Alcohol Alcohol
          <year>2002</year>
<volume>37</volume>
<fpage>81</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">11825862</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bala</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Marcos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gattu</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e96864</fpage>
<pub-id pub-id-type="pmid">24828436</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Uemura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nakatani</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance</article-title>
<source/>Alcohol Clin Exp Res
          <year>2000</year>
<volume>24</volume>
<fpage>48S</fpage>
<lpage>54S</lpage>
<pub-id pub-id-type="pmid">10803780</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajaj</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Heuman</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Hylemon</surname>
<given-names>PB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered profile of human gut microbiome is associated with cirrhosis and its complications</article-title>
<source/>J Hepatol
          <year>2014</year>
<volume>60</volume>
<fpage>940</fpage>
<lpage>947</lpage>
<pub-id pub-id-type="pmid">24374295</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bala</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Catalano</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice</article-title>
<source/>Alcohol Clin Exp Res
          <year>2014</year>
<volume>38</volume>
<fpage>2217</fpage>
<lpage>2224</lpage>
<pub-id pub-id-type="pmid">25156614</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Endo</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacterial translocation and peptidoglycan translocation by acute ethanol administration</article-title>
<source/>J Gastroenterol
          <year>2002</year>
<volume>37</volume>
<fpage>726</fpage>
<lpage>731</lpage>
<pub-id pub-id-type="pmid">12375146</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verma</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles</article-title>
<source/>J Hepatol
          <year>2016</year>
<volume>64</volume>
<fpage>651</fpage>
<lpage>660</lpage>
<pub-id pub-id-type="pmid">26632633</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iracheta-Vellve</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Petrasek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Satishchandran</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice</article-title>
<source/>J Hepatol
          <year>2015</year>
<volume>63</volume>
<fpage>1147</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="pmid">26100496</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>A-M</given-names>
</name>
<name>
<surname>Inamine</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hochrath</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal fungi contribute to development of alcoholic liver disease</article-title>
<source/>J Clin Invest.
          <year>2017</year>
<volume>127</volume>
<fpage>2829</fpage>
<lpage>2841</lpage>
<pub-id pub-id-type="pmid">28530644</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivera</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Adegboyega</surname>
<given-names>P</given-names>
</name>
<name>
<surname>van Rooijen</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis</article-title>
<source/>J Hepatol
          <year>2007</year>
<volume>47</volume>
<fpage>571</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="pmid">17644211</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Amar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic endotoxemia initiates obesity and insulin resistance</article-title>
<source/>Diabetes
          <year>2007</year>
<volume>56</volume>
<fpage>1761</fpage>
<lpage>1772</lpage>
<pub-id pub-id-type="pmid">17456850</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cani</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Bibiloni</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Knauf</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice</article-title>
<source/>Diabetes
          <year>2008</year>
<volume>57</volume>
<fpage>1470</fpage>
<lpage>1481</lpage>
<pub-id pub-id-type="pmid">18305141</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kisseleva</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwaisako</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice</article-title>
<source/>Gastroenterology
          <year>2009</year>
<volume>137</volume>
<issue>1467–1477</issue>
<fpage>e5</fpage>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alisi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Manco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Devito</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>2010</year>
<volume>50</volume>
<fpage>645</fpage>
<lpage>649</lpage>
<pub-id pub-id-type="pmid">20400911</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harte</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>NF</given-names>
</name>
<name>
<surname>Creely</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated endotoxin levels in non-alcoholic fatty liver disease</article-title>
<source/>J Inflamm
          <year>2010</year>
<volume>7</volume>
<fpage>15</fpage>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miura</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease</article-title>
<source/>World J Gastroenterol
          <year>2014</year>
<volume>20</volume>
<fpage>7381</fpage>
<lpage>7391</lpage>
<pub-id pub-id-type="pmid">24966608</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bäckhed</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota as an environmental factor that regulates fat storage</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2004</year>
<volume>101</volume>
<fpage>15718</fpage>
<lpage>15723</lpage>
<pub-id pub-id-type="pmid">15505215</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<mixed-citation publication-type="other">Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA [Internet]. 2007;104:979–84. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/lookup/doi/10.1073/pnas.0605374104">http://www.pnas.org/lookup/doi/10.1073/pnas.0605374104</ext-link>.</mixed-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>Nature
          <year>2006</year>
<volume>444</volume>
<fpage>1027</fpage>
<lpage>1131</lpage>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumas</surname>
<given-names>M-E</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Toye</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2006</year>
<volume>103</volume>
<fpage>12511</fpage>
<lpage>12516</lpage>
<pub-id pub-id-type="pmid">16895997</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nair</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cope</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Terence</surname>
<given-names>RH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis</article-title>
<source/>Am J Gastroenterol
          <year>2001</year>
<volume>96</volume>
<fpage>1200</fpage>
<lpage>1204</lpage>
<pub-id pub-id-type="pmid">11316170</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>FI</given-names>
</name>
</person-group>
<article-title>Immunoglobulins in viral hepatitis and active alcoholic liver-disease</article-title>
<source/>Lancet
          <year>1965</year>
<volume>2</volume>
<fpage>1043</fpage>
<lpage>1046</lpage>
<pub-id pub-id-type="pmid">4159134</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inamine</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>A-M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic loss of immunoglobulin A does not influence development of alcoholic steatohepatitis in mice</article-title>
<source/>Alcohol Clin Exp Res
          <year>2016</year>
<volume>40</volume>
<fpage>2604</fpage>
<lpage>2613</lpage>
<pub-id pub-id-type="pmid">27739086</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldin</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Cattle</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boylston</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>IgA deposition in alcoholic liver disease</article-title>
<source/>J Clin Pathol
          <year>1986</year>
<volume>39</volume>
<fpage>1181</fpage>
<lpage>1185</lpage>
<pub-id pub-id-type="pmid">3540014</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van De Wiel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Delacroix</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Van Hattum</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Characteristics of serum IgA and liver IgA deposits in alcoholic liver disease</article-title>
<source/>Hepatology
          <year>1987</year>
<volume>7</volume>
<fpage>95</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">3542782</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Alcoholic liver disease</article-title>
<source/>Postgrad Med J
          <year>2000</year>
<volume>76</volume>
<fpage>280</fpage>
<lpage>286</lpage>
<pub-id pub-id-type="pmid">10775280</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Elia</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Braulio</surname>
<given-names>VB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of ethanol on gut-associated lymphoid tissues in a model of bacterial translocation: a possible role of apoptosis</article-title>
<source/>Alcohol.
          <year>2003</year>
<volume>30</volume>
<fpage>183</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">13679112</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>López</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Chronic alcohol consumption regulates the expression of poly immunoglobulin receptor (pIgR) and secretory IgA in the gut</article-title>
<source/>Toxicol Appl Pharmacol
          <year>2017</year>
<volume>333</volume>
<fpage>84</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">28843478</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budeč</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Markovic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vignjevic</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal nitric oxide synthase mediates the effect of ethanol on IgA</article-title>
<source/>Alcohol Alcohol
          <year>2013</year>
<volume>48</volume>
<fpage>53</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">23059423</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budeč</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koko</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Todorović</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Possible mechanism of acute effect of ethanol on intestinal IgA expression in rat</article-title>
<source/>Int Immunopharmacol
          <year>2007</year>
<volume>7</volume>
<fpage>858</fpage>
<lpage>863</lpage>
<pub-id pub-id-type="pmid">17466919</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budeč</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Todorović</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Drndarević</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Acute effect of ethanol on IgA immunoreactive cells in the intestine-associated immune system</article-title>
<source/>Pharmacol Rep.
          <year>2005</year>
<volume>57</volume>
<fpage>385</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="pmid">15985723</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelletier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Briantais</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Buffet</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum and intestinal secretory IgA in alcoholic cirrhosis of the liver</article-title>
<source/>Gut
          <year>1982</year>
<volume>23</volume>
<fpage>475</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="pmid">7076021</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colombel</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Vaerman</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Mesnard</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Jejunal immunoglobulin secretion in alcoholic patients with and without cirrhosis</article-title>
<source/>J Hepatol
          <year>1991</year>
<volume>12</volume>
<fpage>145</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">2050993</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bode</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of chronic alcohol abuse on duodenal mononuclear cells in man</article-title>
<source/>Dig Dis Sci
          <year>1999</year>
<volume>44</volume>
<fpage>691</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="pmid">10219824</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomita</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Teratani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum immunoglobulin A concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage</article-title>
<source/>Dig Dis Sci
          <year>2011</year>
<volume>56</volume>
<fpage>3648</fpage>
<lpage>3654</lpage>
<pub-id pub-id-type="pmid">21674175</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McPherson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Burt</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease</article-title>
<source/>J Hepatol
          <year>2014</year>
<volume>60</volume>
<fpage>1055</fpage>
<lpage>1062</lpage>
<pub-id pub-id-type="pmid">24445215</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maleki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Aminafshari</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Taghvaei</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease</article-title>
<source/>World J Gastroenterol
          <year>2014</year>
<volume>20</volume>
<fpage>12566</fpage>
<lpage>12573</lpage>
<pub-id pub-id-type="pmid">25253959</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okazaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kayahara</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consumption of curcumin elevates fecal immunoglobulin A, an index of intestinal immune function, in rats fed a high-fat diet</article-title>
<source/>J Nutr Sci Vitaminol
          <year>2010</year>
<volume>56</volume>
<fpage>68</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="pmid">20354349</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okazaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tomotake</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tsujimoto</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consumption of a resistant protein, sericin, elevates fecal immunoglobulin A, mucins, and cecal organic acids in rats fed a high-fat diet</article-title>
<source/>J Nutr
          <year>2011</year>
<volume>141</volume>
<fpage>1975</fpage>
<lpage>1981</lpage>
<pub-id pub-id-type="pmid">21940508</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ichimura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsuneyama</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<fpage>e0175406</fpage>
<pub-id pub-id-type="pmid">28632732</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W-C</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C-Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats</article-title>
<source/>World J Gastroenterol
          <year>2008</year>
<volume>14</volume>
<fpage>3254</fpage>
<lpage>3258</lpage>
<pub-id pub-id-type="pmid">18506935</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taira</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dietary polyphenols increase fecal mucin and immunoglobulin A and ameliorate the disturbance in gut microbiota caused by a high fat diet</article-title>
<source/>J Clin Biochem Nutr.
          <year>2015</year>
<volume>57</volume>
<fpage>212</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="pmid">26566306</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>N-R</given-names>
</name>
<name>
<surname>Whon</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>J-W</given-names>
</name>
</person-group>
<article-title>Proteobacteria: microbial signature of dysbiosis in gut microbiota</article-title>
<source/>Trends Biotechnol
          <year>2015</year>
<volume>33</volume>
<fpage>496</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="pmid">26210164</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baldridge</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation</article-title>
<source/>Nature
          <year>2015</year>
<volume>521</volume>
<fpage>90</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">25686606</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michail</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease</article-title>
<source/>FEMS Microbiol Ecol
          <year>2015</year>
<volume>91</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">25764541</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease</article-title>
<source/>Sci Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>8096</fpage>
<pub-id pub-id-type="pmid">25644696</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perilla oil has similar protective effects of fish oil on high-fat diet-induced nonalcoholic fatty liver disease and gut dysbiosis</article-title>
<source/>Biomed Res Int
          <year>2016</year>
<volume>2016</volume>
<fpage>9462571</fpage>
<pub-id pub-id-type="pmid">27051672</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raso</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Simeoli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Iacono</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of a <italic>Lactobacillus paracasei</italic> B21060 based synbiotic on steatosis, insulin signaling and Toll-like receptor expression in rats fed a high-fat diet</article-title>
<source/>J Nutr Biochem
          <year>2014</year>
<volume>25</volume>
<fpage>81</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">24314869</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol</article-title>
<source/>Gastroenterology
          <year>2016</year>
<volume>151</volume>
<issue>733–746</issue>
<fpage>e12</fpage>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula</article-title>
<source/>Syst Appl Microbiol
          <year>2013</year>
<volume>36</volume>
<fpage>188</fpage>
<lpage>196</lpage>
<pub-id pub-id-type="pmid">23453736</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boursier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Barret</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota</article-title>
<source/>Hepatology
          <year>2016</year>
<volume>63</volume>
<fpage>764</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="pmid">26600078</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mouzaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Comelli</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Arendt</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbiota in patients with nonalcoholic fatty liver disease</article-title>
<source/>Hepatology
          <year>2013</year>
<volume>58</volume>
<fpage>120</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">23401313</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Fouts</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Brandl</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enteric dysbiosis associated with a mouse model of alcoholic liver disease</article-title>
<source/>Hepatology
          <year>2011</year>
<volume>53</volume>
<fpage>96</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">21254165</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bull-Otterson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kirpich</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metagenomic analyses of alcohol-induced pathogenic alterations in the intestinal microbiome and the effect of<italic> Lactobacillus rhamnosus</italic> GG treatment</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e53028</fpage>
<pub-id pub-id-type="pmid">23326376</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fouts</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Stärkel</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation</article-title>
<source/>Cell Host Microbe
          <year>2016</year>
<volume>19</volume>
<fpage>227</fpage>
<lpage>239</lpage>
<pub-id pub-id-type="pmid">26867181</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirpich</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Solovieva</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Leikhter</surname>
<given-names>SN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study</article-title>
<source/>Alcohol.
          <year>2008</year>
<volume>42</volume>
<fpage>675</fpage>
<lpage>682</lpage>
<pub-id pub-id-type="pmid">19038698</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bluemel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2016</year>
<volume>311</volume>
<fpage>G1018</fpage>
<lpage>G1036</lpage>
<pub-id pub-id-type="pmid">27686615</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mutlu</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Gillevet</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Rangwala</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Colonic microbiome is altered in alcoholism</article-title>
<source/>Am J Physiol Gastrointest Liver Physiol
          <year>2012</year>
<volume>302</volume>
<fpage>G966</fpage>
<lpage>G978</lpage>
<pub-id pub-id-type="pmid">22241860</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Llopis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cassard</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Wrzosek</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease</article-title>
<source/>Gut
          <year>2016</year>
<volume>65</volume>
<fpage>830</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="pmid">26642859</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kakiyama</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pandak</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Gillevet</surname>
<given-names>PM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of the fecal bile acid profile by gut microbiota in cirrhosis</article-title>
<source/>J Hepatol
          <year>2013</year>
<volume>58</volume>
<fpage>949</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="pmid">23333527</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heineke</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>van Egmond</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Immunoglobulin A: magic bullet or Trojan horse?</article-title>
<source/>Eur J Clin Invest
          <year>2017</year>
<volume>47</volume>
<fpage>184</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">28024097</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aleyd</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Heineke</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>van Egmond</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease</article-title>
<source/>Immunol Rev
          <year>2015</year>
<volume>268</volume>
<fpage>123</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">26497517</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Egmond</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Garderen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>van Spriel</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity</article-title>
<source/>Nat Med
          <year>2000</year>
<volume>6</volume>
<fpage>680</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="pmid">10835685</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reljic</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>In search of the elusive mouse macrophage Fc-alpha receptor</article-title>
<source/>Immunol Lett
          <year>2006</year>
<volume>107</volume>
<fpage>80</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">16837064</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<mixed-citation publication-type="other">van der Steen L, Tuk CW, Bakema JE, et al. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology. 2009;137:2018–2029-3.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>